PharVision Advisers’s Verra Mobility VRRM Stock Holding History

PharVision Advisers’s Portfolio VRRM Stock Details VRRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,456	Closed	-$44.4K	–	77
2026 Q2	$44.4K	Buy	+10,456	New	+$110K	0.84%	59
2026 Q1	–	Sell	-10,834	Closed	-$243K	–	641
2025 Q4	$243K	Buy	+10,834	New	+$247K	0.12%	414
2025 Q3	–	Sell	-10,820	Closed	-$275K	–	803
2025 Q2	$275K	Sell	10,820 -1,812	-14%	-$42.2K	0.39%	100
2025 Q1	$284K	Buy	+12,632	New	+$304K	0.39%	100

Other funds holding VRRM

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

PharVision Advisers's VRRM Position: Q3 2026 in Review

PharVision Advisers sold out of Verra Mobility (VRRM) in Q3 2026, closing a stake of 10,456 shares — an estimated $44.4K sold.

PharVision Advisers first reported a position in VRRM in Q1 2025 and held it in 4 quarters. The position peaked at $284K in Q1 2025. 95 funds tracked by Wall St. Rank hold VRRM as of Q3 2026.

PharVision Advisers reported no remaining Verra Mobility position as of Q3 2026 after selling out during the quarter.
PharVision Advisers sold 10,456 Verra Mobility shares in Q3 2026, an estimated $44.4K.
PharVision Advisers first reported a position in Verra Mobility in Q1 2025 and held it in 4 quarters.
PharVision Advisers's Verra Mobility position peaked at $284K in Q1 2025.
95 funds tracked by Wall St. Rank held Verra Mobility as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.